Bloomage BioTechnology Future Growth
Future criteria checks 4/6
Bloomage BioTechnology is forecast to grow earnings and revenue by 29.5% and 15.3% per annum respectively. EPS is expected to grow by 29.4% per annum. Return on equity is forecast to be 11.9% in 3 years.
Key information
29.5%
Earnings growth rate
29.4%
EPS growth rate
| Biotechs earnings growth | 39.2% |
| Revenue growth rate | 15.3% |
| Future return on equity | 11.9% |
| Analyst coverage | Good |
| Last updated | 27 Aug 2024 |
Recent future growth updates
Recent updates
Need To Know: Analysts Just Made A Substantial Cut To Their Bloomage BioTechnology Corporation Limited (SHSE:688363) Estimates
Aug 30
Bloomage BioTechnology Corporation Limited Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 27Bloomage BioTechnology (SHSE:688363) Seems To Use Debt Quite Sensibly
Jun 02Weak Statutory Earnings May Not Tell The Whole Story For Bloomage BioTechnology (SHSE:688363)
May 06Getting In Cheap On Bloomage BioTechnology Corporation Limited (SHSE:688363) Might Be Difficult
May 01Earnings and Revenue Growth Forecasts
| Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
|---|---|---|---|---|---|
| 12/31/2026 | 8,391 | 1,128 | 1,106 | 1,360 | 13 |
| 12/31/2025 | 7,269 | 932 | 1,152 | 1,144 | 14 |
| 12/31/2024 | 6,124 | 708 | -687 | 1,054 | 12 |
| 6/30/2024 | 5,811 | 510 | -145 | 778 | N/A |
| 3/31/2024 | 6,131 | 635 | -24 | 933 | N/A |
| 12/31/2023 | 6,076 | 593 | -331 | 700 | N/A |
| 9/30/2023 | 6,260 | 808 | -192 | 754 | N/A |
| 6/30/2023 | 6,499 | 922 | -357 | 582 | N/A |
| 3/31/2023 | 6,409 | 972 | -149 | 654 | N/A |
| 12/31/2022 | 6,359 | 971 | -61 | 635 | N/A |
| 9/30/2022 | 6,256 | 904 | 159 | 820 | N/A |
| 6/30/2022 | 5,947 | 895 | 482 | 1,131 | N/A |
| 3/31/2022 | 5,426 | 830 | 246 | 1,035 | N/A |
| 12/31/2021 | 4,948 | 782 | 492 | 1,276 | N/A |
| 9/30/2021 | 4,049 | 764 | -30 | 897 | N/A |
| 6/30/2021 | 3,622 | 739 | -223 | 792 | N/A |
| 3/31/2021 | 3,042 | 690 | -179 | 675 | N/A |
| 12/31/2020 | 2,633 | 646 | -58 | 705 | N/A |
| 9/30/2020 | 2,194 | 607 | -15 | 539 | N/A |
| 6/30/2020 | 2,024 | 588 | 140 | 482 | N/A |
| 3/31/2020 | 1,898 | 586 | -23 | 418 | N/A |
| 12/31/2019 | 1,886 | 586 | -85 | 365 | N/A |
| 9/30/2019 | 1,687 | 521 | -48 | 367 | N/A |
| 6/30/2019 | 1,512 | 500 | -22 | 388 | N/A |
| 3/31/2019 | 1,338 | 437 | 83 | 326 | N/A |
| 12/31/2018 | 1,263 | 424 | 274 | 442 | N/A |
| 6/30/2018 | 988 | 330 | 396 | 470 | N/A |
| 3/31/2018 | 903 | 276 | N/A | 407 | N/A |
| 12/31/2017 | 818 | 222 | N/A | 343 | N/A |
| 6/30/2017 | 817 | 201 | N/A | 273 | N/A |
| 3/31/2017 | 830 | 214 | N/A | 228 | N/A |
| 12/31/2016 | 733 | 269 | N/A | 242 | N/A |
| 9/30/2016 | 801 | 214 | N/A | 144 | N/A |
| 6/30/2016 | 757 | 199 | N/A | 105 | N/A |
| 3/31/2016 | 704 | 195 | N/A | 132 | N/A |
| 12/31/2015 | 651 | 190 | N/A | 159 | N/A |
| 9/30/2015 | 600 | 184 | N/A | 153 | N/A |
| 6/30/2015 | 549 | 178 | N/A | 147 | N/A |
| 3/31/2015 | 515 | 170 | N/A | 142 | N/A |
| 12/31/2014 | 481 | 162 | N/A | 137 | N/A |
| 9/30/2014 | 457 | 133 | N/A | 152 | N/A |
| 6/30/2014 | 434 | 105 | N/A | 166 | N/A |
| 3/31/2014 | 404 | 100 | N/A | 161 | N/A |
| 12/31/2013 | 375 | 94 | N/A | 155 | N/A |
| 9/30/2013 | 346 | 100 | N/A | 130 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 688363's forecast earnings growth (29.5% per year) is above the savings rate (2.9%).
Earnings vs Market: 688363's earnings (29.5% per year) are forecast to grow faster than the CN market (23.1% per year).
High Growth Earnings: 688363's earnings are expected to grow significantly over the next 3 years.
Revenue vs Market: 688363's revenue (15.3% per year) is forecast to grow faster than the CN market (13.4% per year).
High Growth Revenue: 688363's revenue (15.3% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 688363's Return on Equity is forecast to be low in 3 years time (11.9%).